FTE UTILIZATION
75.0%
4.5 / 6 FTE
ACTIVE TRIALS
3
of 4 max
ENROLLMENT RATE
3.3
patients/month
PERFORMANCE SCORE
65
out of 100
MONTHLY OP COST
$48K
19% overhead
ACTIVE TRIALS AT THIS SITE
| PROTOCOL | STATUS | ENROLLMENT | SCREEN FAILURES | FTE |
|---|---|---|---|---|
NEURO-PATH-7 Alzheimer's Disease | 58 / 120 48% | 24 | 2.5 |
RECRUITMENT POOLS BY THERAPEUTIC AREA
Neurology
1,160 of 1,400 available
17.1%
+20/mo
Pulmonology
920 of 1,100 available
16.4%
+15/mo
PERFORMANCE BY THERAPEUTIC AREA
| THERAPEUTIC AREA | TRIALS | AVG ENROLLMENT | SCREEN FAILURE | DROPOUT |
|---|---|---|---|---|
| Neurology | 5 | 3.1/mo | 30.0% | 14.0% |
| Pulmonology | 3 | 3.6/mo | 27.0% | 11.0% |
SITE INFORMATION
PRINCIPAL INVESTIGATOR
Dr. Emily Rodriguez, MD
ADDRESS
940 Blackstock Avenue
Knoxville, TN 37916
Knoxville, TN 37916
CONTACT
emily.rodriguez@medpoint.com
(865) 555-0198
CERTIFICATIONS
ACRPGCP
SPECIALTIES
NeurologyPulmonology
CAPACITY BY THERAPEUTIC AREA
Neurology
2 / 2
Pulmonology
1 / 2
HISTORICAL PERFORMANCE
Trials Completed8
On-Time Rate88%
Budget Accuracy±5.4%
Avg Screen Failure29.0%
Avg Dropout13.0%